{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:21:04Z","timestamp":1791177664234,"version":"4.1.0"},"reference-count":156,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Research in Translational Medicine"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.retram.2019.01.005","type":"journal-article","created":{"date-parts":[[2019,1,27]],"date-time":"2019-01-27T07:33:26Z","timestamp":1548574406000},"page":"62-71","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Update of inflammatory proliferative retinopathy: Ischemia, hypoxia and angiogenesis"],"prefix":"10.1016","volume":"67","author":[{"given":"A.","family":"Aouiss","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Anka Idrissi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Kabine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Zaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.retram.2019.01.005_bib0005","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s12974-017-0943-1","article-title":"Retinopathy of prematurity: inflammation, choroidal degeneration, and novel promising therapeutic strategies","volume":"14","author":"Rivera","year":"2017","journal-title":"J Neuroinflamm"},{"issue":"2","key":"10.1016\/j.retram.2019.01.005_bib0010","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2174\/1567202612666150311113535","article-title":"Proliferative retinopathies: animal models and therapeutic opportunities","volume":"12","author":"Villacampa","year":"2015","journal-title":"Curr Neurovasc Res"},{"issue":"12","key":"10.1016\/j.retram.2019.01.005_bib0015","doi-asserted-by":"crossref","first-page":"8590","DOI":"10.1167\/iovs.14-15340","article-title":"Proinflammatory responses induced by CD40 in retinal endothelial and Muller cells are inhibited by blocking CD40-Traf2,3 or CD40-Traf6 signaling","volume":"55","author":"Portillo","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"10.1016\/j.retram.2019.01.005_bib0020","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/dmr.5610110203","article-title":"Retinopathy in animal models of diabetes","volume":"11","author":"Engerman","year":"1995","journal-title":"Diabetes Metab Rev"},{"issue":"1","key":"10.1016\/j.retram.2019.01.005_bib0025","first-page":"101","article-title":"Oxygen-induced retinopathy in the mouse","volume":"35","author":"Smith","year":"1994","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"10.1016\/j.retram.2019.01.005_bib0030","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.preteyeres.2011.05.002","article-title":"Inflammation in diabetic retinopathy","volume":"30","author":"Tang","year":"2011","journal-title":"Prog Retin Eye Res"},{"issue":"13","key":"10.1016\/j.retram.2019.01.005_bib0035","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1056\/NEJMra1005073","article-title":"Diabetic retinopathy","volume":"366","author":"Antonetti","year":"2012","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.retram.2019.01.005_bib0040","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.jacc.2009.03.076","article-title":"The CD40\/CD40 ligand system: linking inflammation with atherothrombosis","volume":"54","author":"Antoniades","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.retram.2019.01.005_bib0045","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/nrrheum.2010.4","article-title":"IL-1 pathways in inflammation and human diseases","volume":"6","author":"Gabay","year":"2010","journal-title":"Nat Rev Rheumatol"},{"issue":"25","key":"10.1016\/j.retram.2019.01.005_bib0050","doi-asserted-by":"crossref","first-page":"18307","DOI":"10.1074\/jbc.M700211200","article-title":"CD40-40L signaling in vascular inflammation","volume":"282","author":"Chakrabarti","year":"2007","journal-title":"J Biol Chem"},{"issue":"10","key":"10.1016\/j.retram.2019.01.005_bib0055","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/S0969-2126(01)00239-8","article-title":"2 A crystal structure of an extracellular fragment of human CD40 ligand","volume":"3","author":"Karpusas","year":"1995","journal-title":"Structure"},{"issue":"4","key":"10.1016\/j.retram.2019.01.005_bib0060","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.2353\/ajpath.2008.070633","article-title":"CD40 ligand promotes Mac-1 expression, leukocyte recruitment, and neointima formation after vascular injury","volume":"172","author":"Li","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1016\/j.retram.2019.01.005_bib0065","doi-asserted-by":"crossref","first-page":"529","DOI":"10.3389\/fimmu.2015.00529","article-title":"The contribution of CD40\/CD40L Axis in inflammatory bowel disease: an update","volume":"6","author":"Senhaji","year":"2015","journal-title":"Front Immunol"},{"issue":"8","key":"10.1016\/j.retram.2019.01.005_bib0070","doi-asserted-by":"crossref","DOI":"10.1161\/01.CIR.0000028962.04520.01","article-title":"Platelet-derived CD40L: the switch-hitting player of cardiovascular disease","volume":"106","author":"Andre","year":"2002","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.retram.2019.01.005_bib0075","doi-asserted-by":"crossref","first-page":"486","DOI":"10.3109\/09537104.2014.932339","article-title":"CD40L expression in plasma of volunteers following LPS administration: a comparison between assay of CD40L on platelet microvesicles and soluble CD40L","volume":"26","author":"Mobarrez","year":"2015","journal-title":"Platelets"},{"issue":"6667","key":"10.1016\/j.retram.2019.01.005_bib0080","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/35393","article-title":"CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells","volume":"391","author":"Henn","year":"1998","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.retram.2019.01.005_bib0085","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nm0302-247","article-title":"CD40L stabilizes arterial thrombi by a beta3 integrin--dependent mechanism","volume":"8","author":"Andre","year":"2002","journal-title":"Nat Med"},{"issue":"21","key":"10.1016\/j.retram.2019.01.005_bib0090","doi-asserted-by":"crossref","first-page":"12367","DOI":"10.1073\/pnas.2032886100","article-title":"Soluble CD40 ligand induces beta3 integrin tyrosine phosphorylation and triggers platelet activation by outside-in signaling","volume":"100","author":"Prasad","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"10.1016\/j.retram.2019.01.005_bib0095","doi-asserted-by":"crossref","first-page":"5143","DOI":"10.1074\/jbc.M608342200","article-title":"CD40 ligand binds to alpha5beta1 integrin and triggers cell signaling","volume":"282","author":"Leveille","year":"2007","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.retram.2019.01.005_bib0100","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/jlb.67.1.2","article-title":"CD40-CD40 ligand","volume":"67","author":"van Kooten","year":"2000","journal-title":"J Leukoc Biol"},{"issue":"12","key":"10.1016\/j.retram.2019.01.005_bib0105","doi-asserted-by":"crossref","first-page":"8719","DOI":"10.4049\/jimmunol.181.12.8719","article-title":"CD40 mediates retinal inflammation and neurovascular degeneration","volume":"181","author":"Portillo","year":"2008","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.retram.2019.01.005_bib0110","doi-asserted-by":"crossref","first-page":"483","DOI":"10.2337\/db16-0051","article-title":"CD40 in retinal muller cells induces P2X7-Dependent cytokine expression in Macrophages\/Microglia in diabetic mice and development of early experimental diabetic retinopathy","volume":"66","author":"Portillo","year":"2017","journal-title":"Diabetes"},{"issue":"11","key":"10.1016\/j.retram.2019.01.005_bib0115","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/15271","article-title":"Requirement for CD154 in the progression of atherosclerosis","volume":"5","author":"Lutgens","year":"1999","journal-title":"Nat Med"},{"issue":"6689","key":"10.1016\/j.retram.2019.01.005_bib0120","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/28204","article-title":"Reduction of atherosclerosis in mice by inhibition of CD40 signalling","volume":"394","author":"Mach","year":"1998","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.retram.2019.01.005_bib0125","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1161\/01.CIR.0000153810.81187.7D","article-title":"Short-term treatment with atorvastatin reduces platelet CD40 ligand and thrombin generation in hypercholesterolemic patients","volume":"111","author":"Sanguigni","year":"2005","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.retram.2019.01.005_bib0130","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1161\/ATVBAHA.110.216143","article-title":"Enhanced levels of soluble CD40 ligand exacerbate platelet aggregation and thrombus formation through a CD40-dependent tumor necrosis factor receptor-associated factor-2\/Rac1\/p38 mitogen-activated protein kinase signaling pathway","volume":"30","author":"Yacoub","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"10","key":"10.1016\/j.retram.2019.01.005_bib0135","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1111\/j.1537-2995.2006.00979.x","article-title":"An association of soluble CD40 ligand (CD154) with adverse reactions to platelet transfusions","volume":"46","author":"Blumberg","year":"2006","journal-title":"Transfusion"},{"key":"10.1016\/j.retram.2019.01.005_bib0140","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/978-0-387-70630-6_11","article-title":"TRAF proteins in CD40 signaling","volume":"597","author":"Bishop","year":"2007","journal-title":"Adv Exp Med Biol"},{"issue":"11","key":"10.1016\/j.retram.2019.01.005_bib0145","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1046\/j.1600-6143.2003.00225.x","article-title":"Prevention of CD40-triggered dendritic cell maturation and induction of T-cell hyporeactivity by targeting of Janus kinase 3","volume":"3","author":"Saemann","year":"2003","journal-title":"Am J Transplant"},{"issue":"5","key":"10.1016\/j.retram.2019.01.005_bib0150","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/S0041-1345(02)02907-X","article-title":"CD40 triggered human monocyte-derived dendritic cells convert to tolerogenic dendritic cells when JAK3 activity is inhibited","volume":"34","author":"Saemann","year":"2002","journal-title":"Transplant Proc"},{"issue":"1","key":"10.1016\/j.retram.2019.01.005_bib0155","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1600-065X.2009.00782.x","article-title":"Molecular mechanism and function of CD40\/CD40L engagement in the immune system","volume":"229","author":"Elgueta","year":"2009","journal-title":"Immunol Rev"},{"issue":"6","key":"10.1016\/j.retram.2019.01.005_bib0160","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1002\/eji.1830250639","article-title":"A soluble form of TRAP (CD40 ligand) is rapidly released after T cell activation","volume":"25","author":"Graf","year":"1995","journal-title":"Eur J Immunol"},{"issue":"8","key":"10.1016\/j.retram.2019.01.005_bib0165","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/nrd3800","article-title":"Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases","volume":"11","author":"Dinarello","year":"2012","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"10.1016\/j.retram.2019.01.005_bib0170","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nri2691","article-title":"The IL-1 family: regulators of immunity","volume":"10","author":"Sims","year":"2010","journal-title":"Nat Rev Immunol"},{"issue":"10","key":"10.1016\/j.retram.2019.01.005_bib0175","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1136\/bjo.2003.038133","article-title":"Role of interleukin-1beta in the pathogenesis of diabetic retinopathy","volume":"88","author":"Kowluru","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.retram.2019.01.005_bib0180","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/4316316","article-title":"Elevated glucose and Interleukin-1beta differentially affect retinal microglial cell proliferation","author":"Baptista","year":"2017","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.retram.2019.01.005_bib0185","article-title":"Preterm birth and neonatal injuries: importance of Interleukin-1 and potential of Interleukin-1 receptor antagonists","author":"Nadeau-Vallee","year":"2017","journal-title":"Curr Pharm Des"},{"issue":"6","key":"10.1016\/j.retram.2019.01.005_bib0190","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3109\/09273948.2011.618902","article-title":"Roles of IL-8 in ocular inflammations: a review","volume":"19","author":"Ghasemi","year":"2011","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.retram.2019.01.005_bib0195","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/9213623","article-title":"Relationship between altered platelet morphological parameters and retinopathy in patients with type 2 diabetes mellitus","author":"Yilmaz","year":"2016","journal-title":"J Ophthalmol"},{"issue":"5","key":"10.1016\/j.retram.2019.01.005_bib0200","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.3906\/sag-1410-95","article-title":"The relationship of mean platelet volume with retinopathy in type 2 diabetes mellitus","volume":"46","author":"Gungor","year":"2016","journal-title":"Turk J Med Sci"},{"issue":"3","key":"10.1016\/j.retram.2019.01.005_bib0205","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/eye.2014.298","article-title":"MPV may reflect subcinical platelet activation in diabetic patients with and without diabetic retinopathy","volume":"29","author":"Citirik","year":"2015","journal-title":"Eye (Lond)"},{"issue":"2","key":"10.1016\/j.retram.2019.01.005_bib0210","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00417-013-2444-y","article-title":"Relationship between mean platelet volume and retinopathy in patients with type 2 diabetes mellitus","volume":"252","author":"Ayhan Tuzcu","year":"2014","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"2","key":"10.1016\/j.retram.2019.01.005_bib0215","first-page":"202","article-title":"Platelet large cell ratio in the differential diagnosis of abnormal platelet counts","volume":"47","author":"Babu","year":"2004","journal-title":"Indian J Pathol Microbiol"},{"issue":"8","key":"10.1016\/j.retram.2019.01.005_bib0220","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.2337\/diacare.24.8.1476","article-title":"Platelet dysfunction in type 2 diabetes","volume":"24","author":"Vinik","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.retram.2019.01.005_bib0225","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.2147\/OPTH.S110749","article-title":"The association of hematologic inflammatory markers with atherogenic index in type 2 diabetic retinopathy patients","volume":"10","author":"Akdogan","year":"2016","journal-title":"Clin Ophthalmol"},{"issue":"1","key":"10.1016\/j.retram.2019.01.005_bib0230","first-page":"28","article-title":"Platelet distribution width: a simple, practical and specific marker of activation of coagulation","volume":"14","author":"Vagdatli","year":"2010","journal-title":"Hippokratia"},{"key":"10.1016\/j.retram.2019.01.005_bib0235","doi-asserted-by":"crossref","first-page":"16017","DOI":"10.1038\/celldisc.2016.17","article-title":"Nuclear localization of platelet-activating factor receptor controls retinal neovascularization","volume":"2","author":"Bhosle","year":"2016","journal-title":"Cell Discov"},{"issue":"9","key":"10.1016\/j.retram.2019.01.005_bib0240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005943","article-title":"Metabolomics analyses identify platelet activating factors and heme breakdown products as Lassa fever biomarkers","volume":"11","author":"Gale","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"10.1016\/j.retram.2019.01.005_bib0245","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/1755-5922.12233","article-title":"Platelet activating factor: a potential biomarker in acute coronary syndrome?","volume":"35","author":"Palur Ramakrishnan","year":"2017","journal-title":"Cardiovasc Ther"},{"issue":"10","key":"10.1016\/j.retram.2019.01.005_bib0250","doi-asserted-by":"crossref","DOI":"10.2174\/1389450115666140903111812","article-title":"PAF receptor and tumor growth","volume":"15","author":"Jancar","year":"2014","journal-title":"Curr Drug Targets"},{"issue":"6","key":"10.1016\/j.retram.2019.01.005_bib0255","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1517\/14728222.2015.1042365","article-title":"Subcellular G-protein coupled receptor signaling hints at greater therapeutic selectivity","volume":"19","author":"Joyal","year":"2015","journal-title":"Expert Opin Ther Targets"},{"issue":"1","key":"10.1016\/j.retram.2019.01.005_bib0260","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-02933-4","article-title":"Membrane ballooning in aggregated platelets is synchronised and mediates a surge in Microvesiculation","volume":"7","author":"Agbani","year":"2017","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.retram.2019.01.005_bib0265","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1093\/cvr\/cvt013","article-title":"High glucose condition increases NADPH oxidase activity in endothelial microparticles that promote vascular inflammation","volume":"98","author":"Jansen","year":"2013","journal-title":"Cardiovasc Res"},{"issue":"4","key":"10.1016\/j.retram.2019.01.005_bib0270","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/aps.2013.188","article-title":"Microvesicles and diabetic complications--novel mediators, potential biomarkers and therapeutic targets","volume":"35","author":"Wang","year":"2014","journal-title":"Acta Pharmacol Sin"},{"issue":"11","key":"10.1016\/j.retram.2019.01.005_bib0275","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1084\/jem.20021868","article-title":"Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin","volume":"197","author":"Falati","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.retram.2019.01.005_bib0280","article-title":"Pathogenic roles of microvesicles in diabetic retinopathy","author":"Zhang","year":"2017","journal-title":"Acta Pharmacol Sin"},{"issue":"13","key":"10.1016\/j.retram.2019.01.005_bib0285","doi-asserted-by":"crossref","first-page":"7897","DOI":"10.1167\/iovs.15-17146","article-title":"BIBF1120 (Vargatef) inhibits preretinal neovascularization and enhances normal vascularization in a model of vasoproliferative retinopathy","volume":"56","author":"Rivera","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"10.1016\/j.retram.2019.01.005_bib0290","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1177\/1947601911423031","article-title":"Vascular endothelial growth factor (VEGF) and its receptor (VEGFR) signaling in angiogenesis: a crucial target for Anti- and pro-angiogenic therapies","volume":"2","author":"Shibuya","year":"2011","journal-title":"Genes Cancer"},{"issue":"9","key":"10.1016\/j.retram.2019.01.005_bib0295","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1172\/JCI67230","article-title":"HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations","volume":"123","author":"Semenza","year":"2013","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.retram.2019.01.005_bib0300","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.cmet.2013.02.002","article-title":"In vivo HIF-mediated reductive carboxylation is regulated by citrate levels and sensitizes VHL-deficient cells to glutamine deprivation","volume":"17","author":"Gameiro","year":"2013","journal-title":"Cell Metab"},{"issue":"2","key":"10.1016\/j.retram.2019.01.005_bib0305","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s11481-014-9531-7","article-title":"Vascular endothelial growth factor signaling in hypoxia and inflammation","volume":"9","author":"Ramakrishnan","year":"2014","journal-title":"J Neuroimmune Pharmacol"},{"issue":"9","key":"10.1016\/j.retram.2019.01.005_bib0310","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a009183","article-title":"Receptor tyrosine kinase-mediated angiogenesis","volume":"5","author":"Jeltsch","year":"2013","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"5","key":"10.1016\/j.retram.2019.01.005_bib0315","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.survophthal.2012.01.007","article-title":"Corneal neovascularization: an anti-VEGF therapy review","volume":"57","author":"Chang","year":"2012","journal-title":"Surv Ophthalmol"},{"issue":"5","key":"10.1016\/j.retram.2019.01.005_bib0320","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nrd2476","article-title":"Therapies for hyperglycaemia-induced diabetic complications: from animal models to clinical trials","volume":"8","author":"Calcutt","year":"2009","journal-title":"Nat Rev Drug Discov"},{"issue":"9","key":"10.1016\/j.retram.2019.01.005_bib0325","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/nrendo.2010.122","article-title":"Effect of systemic medications on onset and progression of diabetic retinopathy","volume":"6","author":"Silva","year":"2010","journal-title":"Nat Rev Endocrinol"},{"issue":"16","key":"10.1016\/j.retram.2019.01.005_bib0330","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1056\/NEJM197304192881609","article-title":"The sorbitol pathway and the complications of diabetes","volume":"288","author":"Gabbay","year":"1973","journal-title":"N Engl J Med"},{"key":"10.1016\/j.retram.2019.01.005_bib0335","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0083-6729(00)60019-5","article-title":"The role of protein kinase C in the development of the complications of diabetes","volume":"60","author":"Ways","year":"2000","journal-title":"Vitam Horm"},{"issue":"1","key":"10.1016\/j.retram.2019.01.005_bib0340","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2337\/diabetes.48.1.1","article-title":"Role of oxidative stress in diabetic complications: a new perspective on an old paradigm","volume":"48","author":"Baynes","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.retram.2019.01.005_bib0345","doi-asserted-by":"crossref","DOI":"10.1155\/2007\/95103","article-title":"Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy","author":"Kern","year":"2007","journal-title":"Exp Diabetes Res"},{"issue":"Pt 4","key":"10.1016\/j.retram.2019.01.005_bib0350","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/eye.1999.130","article-title":"Bowman Lecture 1998. Diabetic retinopathy: some cellular, molecular and therapeutic considerations","volume":"13","author":"Archer","year":"1999","journal-title":"Eye (Lond)"},{"issue":"19","key":"10.1016\/j.retram.2019.01.005_bib0355","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1001\/jama.287.19.2563","article-title":"Complications Trial\/Epidemiology of Diabetes I, Complications Research G. Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus","volume":"287","author":"Writing Team for the Diabetes C","year":"2002","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.retram.2019.01.005_bib0360","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1172\/JCI0213776","article-title":"Acute intensive insulin therapy exacerbates diabetic blood-retinal barrier breakdown via hypoxia-inducible factor-1alpha and VEGF","volume":"109","author":"Poulaki","year":"2002","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.retram.2019.01.005_bib0365","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/00006982-200605000-00011","article-title":"Diabetic macular edema associated with glitazone use","volume":"26","author":"Ryan","year":"2006","journal-title":"Retina"},{"issue":"12","key":"10.1016\/j.retram.2019.01.005_bib0370","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.2337\/diabetes.54.12.3418","article-title":"Aspirin at low-intermediate concentrations protects retinal vessels in experimental diabetic retinopathy through non-platelet-mediated effects","volume":"54","author":"Sun","year":"2005","journal-title":"Diabetes"},{"issue":"7","key":"10.1016\/j.retram.2019.01.005_bib0375","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0008-4182(00)80126-X","article-title":"Prevalence of ocular hemorrhage in patients receiving warfarin therapy","volume":"35","author":"Superstein","year":"2000","journal-title":"Can J Ophthalmol"},{"issue":"2","key":"10.1016\/j.retram.2019.01.005_bib0380","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2337\/db06-0789","article-title":"Salicylate-based anti-inflammatory drugs inhibit the early lesion of diabetic retinopathy","volume":"56","author":"Zheng","year":"2007","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.retram.2019.01.005_bib0385","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2337\/dc07-1338","article-title":"Salsalate improves glycemia and inflammatory parameters in obese young adults","volume":"31","author":"Fleischman","year":"2008","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.retram.2019.01.005_bib0390","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/00006982-200603000-00016","article-title":"Regression of retinal and iris neovascularization after intravitreal bevacizumab (Avastin) treatment","volume":"26","author":"Avery","year":"2006","journal-title":"Retina"},{"issue":"10","key":"10.1016\/j.retram.2019.01.005_bib0395","first-page":"1263","article-title":"Effect of niacin on lipid and lipoprotein levels and glycemic control in patients with diabetes and peripheral arterial disease: the ADMIT study: a randomized trial","volume":"284","author":"Elam","year":"2000","journal-title":"Arterial Disease Multiple Intervention Trial. JAMA."},{"issue":"1","key":"10.1016\/j.retram.2019.01.005_bib0400","doi-asserted-by":"crossref","first-page":"17","DOI":"10.7150\/ijms.7329","article-title":"Hypoxia-induced deregulation of miR-126 and its regulative effect on VEGF and MMP-9 expression","volume":"11","author":"Ye","year":"2014","journal-title":"Int J Med Sci"},{"issue":"2","key":"10.1016\/j.retram.2019.01.005_bib0405","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.devcel.2008.06.002","article-title":"A casein kinase 1 and PAR proteins regulate asymmetry of a PIP(2) synthesis enzyme for asymmetric spindle positioning","volume":"15","author":"Panbianco","year":"2008","journal-title":"Dev Cell"},{"key":"10.1016\/j.retram.2019.01.005_bib0410","article-title":"MicroRNA-126 contributes to Niaspan treatment induced vascular restoration after diabetic retinopathy","volume":"6","author":"Wang","year":"2016","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.retram.2019.01.005_bib0415","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.expneurol.2011.09.022","article-title":"Niaspan enhances vascular remodeling after stroke in type 1 diabetic rats","volume":"232","author":"Ye","year":"2011","journal-title":"Exp Neurol"},{"issue":"3","key":"10.1016\/j.retram.2019.01.005_bib0420","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2174\/15701611113119990017","article-title":"The role of microRNA-126 in vascular homeostasis","volume":"13","author":"van Solingen","year":"2015","journal-title":"Curr Vasc Pharmacol"},{"issue":"10","key":"10.1016\/j.retram.2019.01.005_bib0425","doi-asserted-by":"crossref","first-page":"4867","DOI":"10.1167\/iovs.10-5881","article-title":"AGEs and diabetic retinopathy","volume":"51","author":"Stitt","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"10.1016\/j.retram.2019.01.005_bib0430","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.cell.2014.01.043","article-title":"Glycosylation-dependent lectin-receptor interactions preserve angiogenesis in anti-VEGF refractory tumors","volume":"156","author":"Croci","year":"2014","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.retram.2019.01.005_bib0435","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-16499-8","article-title":"Advanced glycation endproducts link inflammatory cues to upregulation of galectin-1 in diabetic retinopathy","volume":"7","author":"Kanda","year":"2017","journal-title":"Sci Rep"},{"issue":"15","key":"10.1016\/j.retram.2019.01.005_bib0440","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1056\/NEJMoa065213","article-title":"Interleukin-1-receptor antagonist in type 2 diabetes mellitus","volume":"356","author":"Larsen","year":"2007","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.retram.2019.01.005_bib0445","doi-asserted-by":"crossref","first-page":"224","DOI":"10.2337\/db06-0427","article-title":"Inhibition of caspase-1\/interleukin-1beta signaling prevents degeneration of retinal capillaries in diabetes and galactosemia","volume":"56","author":"Vincent","year":"2007","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.retram.2019.01.005_bib0450","doi-asserted-by":"crossref","first-page":"879","DOI":"10.3899\/jrheum.091046","article-title":"Macrophage activation syndrome treated with anakinra","volume":"37","author":"Durand","year":"2010","journal-title":"J Rheumatol"},{"issue":"6","key":"10.1016\/j.retram.2019.01.005_bib0455","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.cell.2010.02.043","article-title":"Anti-inflammatory agents: present and future","volume":"140","author":"Dinarello","year":"2010","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.retram.2019.01.005_bib0460","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.ajpath.2014.10.020","article-title":"Retinal neurons curb inflammation and enhance revascularization in ischemic retinopathies via proteinase-activated receptor-2","volume":"185","author":"Sitaras","year":"2015","journal-title":"Am J Pathol"},{"issue":"11","key":"10.1016\/j.retram.2019.01.005_bib0465","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.363","article-title":"Knockout of Ccr2 alleviates photoreceptor cell death in rodent retina exposed to chronic blue light","volume":"7","author":"Hu","year":"2016","journal-title":"Cell Death Dis"},{"issue":"7","key":"10.1016\/j.retram.2019.01.005_bib0470","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.308","article-title":"Protection of Mcc950 against high-glucose-induced human retinal endothelial cell dysfunction","volume":"8","author":"Zhang","year":"2017","journal-title":"Cell Death Dis"},{"issue":"1","key":"10.1016\/j.retram.2019.01.005_bib0475","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s10753-016-0449-5","article-title":"Activation of the NLRP3 inflammasome is associated with valosin-containing protein myopathy","volume":"40","author":"Nalbandian","year":"2017","journal-title":"Inflammation"},{"issue":"3","key":"10.1016\/j.retram.2019.01.005_bib0480","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/ni.3333","article-title":"NLRP3 activation and mitosis are mutually exclusive events coordinated by NEK7, a new inflammasome component","volume":"17","author":"Shi","year":"2016","journal-title":"Nat Immunol"},{"issue":"3","key":"10.1016\/j.retram.2019.01.005_bib0485","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1074\/jbc.M511153200","article-title":"Interleukin-1beta induction of NFkappaB is partially regulated by H2O2-mediated activation of NFkappaB-inducing kinase","volume":"281","author":"Li","year":"2006","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.retram.2019.01.005_bib0490","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/sj.gt.3301878","article-title":"Lentivirus-mediated expression of angiostatin efficiently inhibits neovascularization in a murine proliferative retinopathy model","volume":"10","author":"Igarashi","year":"2003","journal-title":"Gene Ther"},{"issue":"2","key":"10.1016\/j.retram.2019.01.005_bib0495","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0092-8674(94)90200-3","article-title":"Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma","volume":"79","author":"O\u2019Reilly","year":"1994","journal-title":"Cell"},{"issue":"6A","key":"10.1016\/j.retram.2019.01.005_bib0500","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1111\/j.1582-4934.2008.00243.x","article-title":"Deguelin inhibits retinal neovascularization by down-regulation of HIF-1alpha in oxygen-induced retinopathy","volume":"12","author":"Kim","year":"2008","journal-title":"J Cell Mol Med"},{"issue":"22","key":"10.1016\/j.retram.2019.01.005_bib0505","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1093\/jnci\/dji377","article-title":"Chemopreventive effects of deguelin, a novel Akt inhibitor, on tobacco-induced lung tumorigenesis","volume":"97","author":"Lee","year":"2005","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"10.1016\/j.retram.2019.01.005_bib0510","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.ccell.2017.10.003","article-title":"An HIF-1alpha\/VEGF-A Axis in cytotoxic t cells regulates tumor progression","volume":"32","author":"Palazon","year":"2017","journal-title":"Cancer Cell"},{"issue":"22","key":"10.1016\/j.retram.2019.01.005_bib0515","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.1007\/s00018-009-0147-7","article-title":"Hypoxia, hypoxia-inducible factors (HIF), HIF hydroxylases and oxygen sensing","volume":"66","author":"Webb","year":"2009","journal-title":"Cell Mol Life Sci"},{"issue":"10","key":"10.1016\/j.retram.2019.01.005_bib0520","doi-asserted-by":"crossref","first-page":"7565","DOI":"10.1167\/iovs.11-8002","article-title":"Reduced retinal neovascularization, vascular permeability, and apoptosis in ischemic retinopathy in the absence of prolyl hydroxylase-1 due to the prevention of hyperoxia-induced vascular obliteration","volume":"52","author":"Huang","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"10.1016\/j.retram.2019.01.005_bib0525","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nrd2761","article-title":"Inhibition of oxygen sensors as a therapeutic strategy for ischaemic and inflammatory disease","volume":"8","author":"Fraisl","year":"2009","journal-title":"Nat Rev Drug Discov"},{"issue":"1-2","key":"10.1016\/j.retram.2019.01.005_bib0530","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s11010-014-2212-2","article-title":"Effects of p75 neurotrophin receptor on regulating hypoxia-induced angiogenic factors in retinal pigment epithelial cells","volume":"398","author":"Zhang","year":"2015","journal-title":"Mol Cell Biochem"},{"issue":"1-2","key":"10.1016\/j.retram.2019.01.005_bib0535","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0169-328X(02)00185-7","article-title":"Expression of p75(NTR) in photoreceptor cells of dystrophic rat retinas","volume":"103","author":"Sheedlo","year":"2002","journal-title":"Brain Res Mol Brain Res"},{"issue":"2","key":"10.1016\/j.retram.2019.01.005_bib0540","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCRESAHA.108.177386","article-title":"Neurotrophin p75 receptor (p75NTR) promotes endothelial cell apoptosis and inhibits angiogenesis: implications for diabetes-induced impaired neovascularization in ischemic limb muscles","volume":"103","author":"Caporali","year":"2008","journal-title":"Circ Res"},{"issue":"3","key":"10.1016\/j.retram.2019.01.005_bib0545","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1152\/physrev.00021.2004","article-title":"The retinal pigment epithelium in visual function","volume":"85","author":"Strauss","year":"2005","journal-title":"Physiol Rev"},{"issue":"6","key":"10.1016\/j.retram.2019.01.005_bib0550","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.2353\/ajpath.2006.050588","article-title":"Inhibition of platelet-derived growth factor B signaling enhances the efficacy of anti-vascular endothelial growth factor therapy in multiple models of ocular neovascularization","volume":"168","author":"Jo","year":"2006","journal-title":"Am J Pathol"},{"issue":"1","key":"10.1016\/j.retram.2019.01.005_bib0555","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1136\/bjo.2007.122283","article-title":"Efficacy of intravitreal bevacizumab for polypoidal choroidal vasculopathy","volume":"92","author":"Gomi","year":"2008","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"10.1016\/j.retram.2019.01.005_bib0560","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nrc1360","article-title":"The discovery of receptor tyrosine kinases: targets for cancer therapy","volume":"4","author":"Gschwind","year":"2004","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"10.1016\/j.retram.2019.01.005_bib0565","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/S0002-9440(10)63214-2","article-title":"Inhibition of platelet-derived growth factor promotes pericyte loss and angiogenesis in ischemic retinopathy","volume":"164","author":"Wilkinson-Berka","year":"2004","journal-title":"Am J Pathol"},{"issue":"12","key":"10.1016\/j.retram.2019.01.005_bib0570","doi-asserted-by":"crossref","first-page":"4774","DOI":"10.1158\/0008-5472.CAN-07-6307","article-title":"BIBF 1120: triple angiokinase inhibitor with sustained receptor blockade and good antitumor efficacy","volume":"68","author":"Hilberg","year":"2008","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.retram.2019.01.005_bib0575","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-15602-3","article-title":"An apelin receptor antagonist prevents pathological retinal angiogenesis with ischemic retinopathy in mice","volume":"7","author":"Ishimaru","year":"2017","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.retram.2019.01.005_bib0580","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1006\/bbrc.1998.9489","article-title":"Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor","volume":"251","author":"Tatemoto","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"issue":"10","key":"10.1016\/j.retram.2019.01.005_bib0585","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1161\/ATVBAHA.108.163402","article-title":"Retardation of retinal vascular development in apelin-deficient mice","volume":"28","author":"Kasai","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"15","key":"10.1016\/j.retram.2019.01.005_bib0590","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1182\/blood-2009-07-232306","article-title":"Apelin induces enlarged and nonleaky blood vessels for functional recovery from ischemia","volume":"115","author":"Kidoya","year":"2010","journal-title":"Blood"},{"issue":"19","key":"10.1016\/j.retram.2019.01.005_bib0595","doi-asserted-by":"crossref","first-page":"4025","DOI":"10.1182\/blood-2010-02-270819","article-title":"Identification and functional analysis of endothelial tip cell-enriched genes","volume":"116","author":"del Toro","year":"2010","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.retram.2019.01.005_bib0600","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s10456-013-9349-6","article-title":"Inhibition of apelin expression switches endothelial cells from proliferative to mature state in pathological retinal angiogenesis","volume":"16","author":"Kasai","year":"2013","journal-title":"Angiogenesis"},{"key":"10.1016\/j.retram.2019.01.005_bib0605","article-title":"Evaluation of the plasma microRNA levels in stage 3 premature retinopathy with plus disease: preliminary study","author":"Metin","year":"2017","journal-title":"Eye (Lond)"},{"issue":"4","key":"10.1016\/j.retram.2019.01.005_bib0610","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/cvr\/cvs003","article-title":"MicroRNA-214 inhibits angiogenesis by targeting Quaking and reducing angiogenic growth factor release","volume":"93","author":"van Mil","year":"2012","journal-title":"Cardiovasc Res"},{"issue":"6","key":"10.1016\/j.retram.2019.01.005_bib0615","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nrd.2015.17","article-title":"Ten years of anti-vascular endothelial growth factor therapy","volume":"15","author":"Ferrara","year":"2016","journal-title":"Nat Rev Drug Discov"},{"issue":"9","key":"10.1016\/j.retram.2019.01.005_bib0620","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/nrd.2016.278","article-title":"Therapeutic targeting of the angiopoietin-TIE pathway","volume":"16","author":"Saharinen","year":"2017","journal-title":"Nat Rev Drug Discov"},{"issue":"13","key":"10.1016\/j.retram.2019.01.005_bib0625","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1084\/jem.20150718","article-title":"Interfering with VE-PTP stabilizes endothelial junctions in vivo via Tie-2 in the absence of VE-cadherin","volume":"212","author":"Frye","year":"2015","journal-title":"J Exp Med"},{"issue":"9","key":"10.1016\/j.retram.2019.01.005_bib0630","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.yexcr.2013.03.011","article-title":"Angiopoietin signaling in the vasculature","volume":"319","author":"Eklund","year":"2013","journal-title":"Exp Cell Res"},{"issue":"1","key":"10.1016\/j.retram.2019.01.005_bib0635","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.molmed.2012.10.010","article-title":"Orchestral actions of angiopoietin-1 in vascular regeneration","volume":"19","author":"Koh","year":"2013","journal-title":"Trends Mol Med"},{"issue":"7","key":"10.1016\/j.retram.2019.01.005_bib0640","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1161\/01.RES.87.7.603","article-title":"Angiopoietin-1 is an antipermeability and anti-inflammatory agent in vitro and targets cell junctions","volume":"87","author":"Gamble","year":"2000","journal-title":"Circ Res"},{"issue":"8","key":"10.1016\/j.retram.2019.01.005_bib0645","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0070459","article-title":"Angiopoietin-2 is critical for cytokine-induced vascular leakage","volume":"8","author":"Benest","year":"2013","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.retram.2019.01.005_bib0650","doi-asserted-by":"crossref","DOI":"10.1097\/CCM.0000000000000993","article-title":"Drug repurposing screen identifies Foxo1-Dependent Angiopoietin-2 regulation in Sepsis","volume":"43","author":"Ghosh","year":"2015","journal-title":"Crit Care Med"},{"issue":"9","key":"10.1016\/j.retram.2019.01.005_bib0655","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1172\/JCI84923","article-title":"Tie1 controls angiopoietin function in vascular remodeling and inflammation","volume":"126","author":"Korhonen","year":"2016","journal-title":"J Clin Invest"},{"issue":"1-2","key":"10.1016\/j.retram.2019.01.005_bib0660","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0009-2797(89)90059-8","article-title":"Singlet oxygen production by biological systems","volume":"70","author":"Kanofsky","year":"1989","journal-title":"Chem Biol Interact"},{"issue":"9","key":"10.1016\/j.retram.2019.01.005_bib0665","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.2337\/db13-1942","article-title":"Angiopoietin 2 induces pericyte apoptosis via alpha3beta1 integrin signaling in diabetic retinopathy","volume":"63","author":"Park","year":"2014","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.retram.2019.01.005_bib0670","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1083\/jcb.200507082","article-title":"Stable interaction between alpha5beta1 integrin and Tie2 tyrosine kinase receptor regulates endothelial cell response to Ang-1","volume":"170","author":"Cascone","year":"2005","journal-title":"J Cell Biol"},{"issue":"3","key":"10.1016\/j.retram.2019.01.005_bib0675","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/jcp.21558","article-title":"The angiopoietin-2 gene of endothelial cells is up-regulated in hypoxia by a HIF binding site located in its first intron and by the central factors GATA-2 and Ets-1","volume":"217","author":"Simon","year":"2008","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.retram.2019.01.005_bib0680","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1146\/annurev-physiol-021115-105412","article-title":"Vascular growth factors and glomerular disease","volume":"78","author":"Bartlett","year":"2016","journal-title":"Annu Rev Physiol"},{"issue":"1","key":"10.1016\/j.retram.2019.01.005_bib0685","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00592-015-0752-x","article-title":"Nucleoside diphosphate kinase B deficiency causes a diabetes-like vascular pathology via up-regulation of endothelial angiopoietin-2 in the retina","volume":"53","author":"Qiu","year":"2016","journal-title":"Acta Diabetol"},{"issue":"4","key":"10.1016\/j.retram.2019.01.005_bib0690","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.2337\/diabetes.53.4.1104","article-title":"Angiopoietin-2 causes pericyte dropout in the normal retina: evidence for involvement in diabetic retinopathy","volume":"53","author":"Hammes","year":"2004","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.retram.2019.01.005_bib0695","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1172\/JCI46322","article-title":"Angiopoietin-1 is essential in mouse vasculature during development and in response to injury","volume":"121","author":"Jeansson","year":"2011","journal-title":"J Clin Invest"},{"issue":"10","key":"10.1016\/j.retram.2019.01.005_bib0700","doi-asserted-by":"crossref","DOI":"10.1097\/CCM.0000000000000524","article-title":"Lung-targeted RNA interference against angiopoietin-2 ameliorates multiple organ dysfunction and death in sepsis","volume":"42","author":"Stiehl","year":"2014","journal-title":"Crit Care Med"},{"issue":"335","key":"10.1016\/j.retram.2019.01.005_bib0705","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aad9260","article-title":"Amelioration of sepsis by TIE2 activation-induced vascular protection","volume":"8","author":"Han","year":"2016","journal-title":"Sci Transl Med"},{"issue":"203","key":"10.1016\/j.retram.2019.01.005_bib0710","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3006666","article-title":"Angiopoietin-1 guides directional angiogenesis through integrin alphavbeta5 signaling for recovery of ischemic retinopathy","volume":"5","author":"Lee","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.retram.2019.01.005_bib0715","article-title":"Tissue regeneration using endothelial colony-forming cells: promising cells for vascular repair","author":"Banno","year":"2017","journal-title":"Pediatr Res"},{"issue":"11","key":"10.1016\/j.retram.2019.01.005_bib0720","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1038\/nprot.2009.187","article-title":"Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis","volume":"4","author":"Connor","year":"2009","journal-title":"Nat Protoc"},{"issue":"11","key":"10.1016\/j.retram.2019.01.005_bib0725","doi-asserted-by":"crossref","first-page":"5906","DOI":"10.1167\/iovs.09-4951","article-title":"Outgrowth endothelial cells: characterization and their potential for reversing ischemic retinopathy","volume":"51","author":"Medina","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"10.1016\/j.retram.2019.01.005_bib0730","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.89906","article-title":"CD44 expression in endothelial colony-forming cells regulates neurovascular trophic effect","volume":"2","author":"Sakimoto","year":"2017","journal-title":"JCI Insight"},{"issue":"10","key":"10.1016\/j.retram.2019.01.005_bib0735","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1038\/eye.2016.94","article-title":"Revisiting the role of erythropoietin for treatment of ocular disorders","volume":"30","author":"Shirley Ding","year":"2016","journal-title":"Eye (Lond)"},{"issue":"10","key":"10.1016\/j.retram.2019.01.005_bib0740","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.bcp.2011.06.045","article-title":"Erythropoietin, erythropoiesis and beyond","volume":"82","author":"Chateauvieux","year":"2011","journal-title":"Biochem Pharmacol"},{"issue":"6","key":"10.1016\/j.retram.2019.01.005_bib0745","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.2337\/dc07-2075","article-title":"Expression of erythropoietin and its receptor in the human retina: a comparative study of diabetic and nondiabetic subjects","volume":"31","author":"Garcia-Ramirez","year":"2008","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.retram.2019.01.005_bib0750","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055291","article-title":"Erythropoietin protects adult retinal ganglion cells against NMDA-, trophic factor withdrawal-, and TNF-alpha-induced damage","volume":"8","author":"Chang","year":"2013","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.retram.2019.01.005_bib0755","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.freeradbiomed.2008.11.027","article-title":"Erythropoietin protects retinal pigment epithelial cells from oxidative damage","volume":"46","author":"Wang","year":"2009","journal-title":"Free Radic Biol Med"},{"issue":"1-2","key":"10.1016\/j.retram.2019.01.005_bib0760","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jneuroim.2005.10.016","article-title":"Delayed administration of erythropoietin and its non-erythropoietic derivatives ameliorates chronic murine autoimmune encephalomyelitis","volume":"172","author":"Savino","year":"2006","journal-title":"J Neuroimmunol"},{"issue":"2","key":"10.1016\/j.retram.2019.01.005_bib0765","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1167\/iovs.07-0721","article-title":"Intravitreal injection of erythropoietin protects both retinal vascular and neuronal cells in early diabetes","volume":"49","author":"Zhang","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"10.1016\/j.retram.2019.01.005_bib0770","first-page":"526","article-title":"Erythropoietin deficiency decreases vascular stability in mice","volume":"118","author":"Chen","year":"2008","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.retram.2019.01.005_bib0775","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.yjmcc.2009.09.005","article-title":"Carbamylated darbepoetin derivative prevents endothelial progenitor cell damage with no effect on angiogenesis","volume":"47","author":"Ramirez","year":"2009","journal-title":"J Mol Cell Cardiol"},{"issue":"8","key":"10.1016\/j.retram.2019.01.005_bib0780","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1007\/s00417-015-2969-3","article-title":"Carbamylated erythropoietin mediates retinal neuroprotection in streptozotocin-induced early-stage diabetic rats","volume":"253","author":"Liu","year":"2015","journal-title":"Graefes Arch Clin Exp Ophthalmol"}],"container-title":["Current Research in Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452318619300054?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452318619300054?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:38:07Z","timestamp":1762821487000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452318619300054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":156,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S2452318619300054"],"URL":"https:\/\/doi.org\/10.1016\/j.retram.2019.01.005","relation":{},"ISSN":["2452-3186"],"issn-type":[{"value":"2452-3186","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Update of inflammatory proliferative retinopathy: Ischemia, hypoxia and angiogenesis","name":"articletitle","label":"Article Title"},{"value":"Current Research in Translational Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.retram.2019.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}